KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Acquisitions & Divestments (2021 - 2025)

AbCellera Biologics' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $119.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 40.79% year-over-year to $119.5 million, compared with a TTM value of $506.1 million through Dec 2025, down 46.04%, and an annual FY2025 reading of $506.1 million, down 46.04% over the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $119.5 million at AbCellera Biologics, up from $83.1 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $306.5 million in Q1 2024, with the low at $18.1 million in Q4 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $169.6 million, with a median of $190.0 million recorded in 2025.
  • Year-over-year, Change in Acquisitions & Divestments soared 410.99% in 2022 and then crashed 57.73% in 2025.
  • Tracing ABCL's Change in Acquisitions & Divestments over 5 years: stood at $18.1 million in 2021, then soared by 410.99% to $92.4 million in 2022, then soared by 190.09% to $268.0 million in 2023, then fell by 24.67% to $201.9 million in 2024, then tumbled by 40.79% to $119.5 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Change in Acquisitions & Divestments are $119.5 million (Q4 2025), $83.1 million (Q3 2025), and $113.4 million (Q2 2025).